Elanco Animal Health Inc. ELAN Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.69B+3.9% | $2.59B+2.8% | $2.52B+2.8% | $2.45B+1.0% | $2.43B-0.2% | ||
| $237M+7.7% | $220M+18.3% | $186M-3.1% | $192M-8.1% | $209M-11.1% | ||
| -$242M-4.3% | -$232M-627% | $44M-90.0% | $442M+16.0% | $381M+10.1% | ||
| $731M+8.1% | $676M— | —— | —— | —— | ||
| $40M+1,100% | -$4M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Elanco Animal Health Inc.'s revenue?
- Elanco Animal Health Inc. (ELAN) generated $4.9B in revenue over the trailing twelve months, up 10.5% year over year.
- Is Elanco Animal Health Inc. profitable?
- Elanco Animal Health Inc. is not currently profitable: it reported a net loss of $242.0M over the trailing twelve months, a -4.9% net margin.
- What is Elanco Animal Health Inc.'s earnings per share?
- Elanco Animal Health Inc.'s diluted EPS over the trailing twelve months is $-0.50.
- Where does Elanco Animal Health Inc.'s income statement data come from?
- Every line is extracted from Elanco Animal Health Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
